AHC
JAZZ icon

Adell Harriman & Carpenter’s Jazz Pharmaceuticals JAZZ Stock Holding History

Adell Harriman & Carpenter’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,900
Closed -$247K – 181
2021
Q3 		$247K Sell
1,900
-2,600
-58% -$393K 0.03% 166
2021
Q2 		$799K Sell
4,500
-50
-1% -$8.66K 0.08% 114
2021
Q1 		$748K Buy
4,550
+950
+26% +$156K 0.09% 108
2020
Q4 		$594K Buy
3,600
+200
+6% +$29.8K 0.08% 108
2020
Q3 		$485K Buy
3,400
+1,050
+45% +$130K 0.07% 113
2020
Q2 		$259K Sell
2,350
-1,750
-43% -$194K 0.04% 119
2020
Q1 		$409K Sell
4,100
-1,250
-23% -$162K 0.09% 100
2019
Q4 		$799K Sell
5,350
-1,050
-16% -$143K 0.13% 95
2019
Q3 		$820K Sell
6,400
-4,175
-39% -$560K 0.15% 93
2019
Q2 		$1.51M Sell
10,575
-680
-6% -$91.4K 0.28% 79
2019
Q1 		$1.61M Buy
11,255
+2,020
+22% +$263K 0.31% 71
2018
Q4 		$1.14M Sell
9,235
-4,655
-34% -$691K 0.25% 81
2018
Q3 		$2.34M Buy
13,890
+100
+0.7% +$17.2K 0.44% 60
2018
Q2 		$2.38M Buy
13,790
+400
+3% +$65.4K 0.47% 57
2018
Q1 		$2.02M Buy
13,390
+1,475
+12% +$216K 0.42% 60
2017
Q4 		$1.6M Sell
11,915
-4,825
-29% -$669K 0.34% 74
2017
Q3 		$2.45M Sell
16,740
-200
-1% -$30.2K 0.53% 56
2017
Q2 		$2.63M Buy
16,940
+6,200
+58% +$948K 0.6% 55
2017
Q1 		$1.56M Buy
+10,740
New +$1.4M 0.36% 71
2015
Q4 		– Sell
-4,255
Closed -$565K – 141
2015
Q3 		$565K Sell
4,255
-2,785
-40% -$480K 0.17% 96
2015
Q2 		$1.24M Hold
7,040
– – 0.32% 73
2015
Q1 		$1.22M Buy
7,040
+1,990
+39% +$342K 0.32% 78
2014
Q4 		$827K Buy
+5,050
New +$838K 0.23% 86

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Adell Harriman & Carpenter's JAZZ Position: Q4 2021 in Review

Adell Harriman & Carpenter sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 1,900 shares — an estimated $247K sold.

Adell Harriman & Carpenter first reported a position in JAZZ in Q4 2014 and held it in 23 quarters. The position peaked at $2.63M in Q2 2017. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

  • Adell Harriman & Carpenter reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Adell Harriman & Carpenter sold 1,900 Jazz Pharmaceuticals shares in Q4 2021, an estimated $247K.
  • Adell Harriman & Carpenter first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 23 quarters.
  • Adell Harriman & Carpenter's Jazz Pharmaceuticals position peaked at $2.63M in Q2 2017.
  • 454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Adell Harriman & Carpenter's 13F filing for Q4 2021, filed 16 Feb 2022.